Latest Heart Protection Study Stories
The largest randomized study of the vitamin niacin in patients with occlusive arterial disease (narrowing of the arteries) has shown a significant increase in adverse side-effects when it is combined with statin treatment.
Merck is telling doctors to stop prescribing the cholesterol drug Tredaptive following a study that casts doubt on the medication’s efficacy and safety.
Many women use vitamin E for their skin, but theories have circulated that taking vitamin E could also impact a women's heart.
Among patients who have had an ischemic stroke, use of cholesterol-lowering statin medications is not associated with subsequent intracerebral hemorrhage (bleeding in the brain).
Increased risk of muscle injury cited SILVER SPRING, Md., June 8, 2011 /PRNewswire-USNewswire/ -- The U.S.
Regardless of the beneficial effects of both aspirin and simvastatin in treating heart disease, neither drug appears to offer any benefit to individuals suffering from pulmonary artery hypertension (PAH), a condition that accounts for over 1,000 new cases annually.
A computer decision model suggests that for patients with a history of bleeding within the brain, the risk of recurrence associated with statin treatment may outweigh the benefit of the drug in preventing cardiovascular disease.
Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk.
Highest approved dose of cholesterol-lowering medication could cause harm to muscles SILVER SPRING, Md., March 19 /PRNewswire-USNewswire/ -- The U.S.